VANCOUVER, Dec. 6 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, is scheduled to participate in the RBC 2007 Healthcare Conference, which is being held December 12-13 in New York, NY.
Tom Bailey, Angiotech's Chief Financial Officer, is scheduled to participate in a panel discussion on Thursday, December 13, at the Westin New York Times Square, beginning at approximately 9:00am ET.
A live audio-only webcast will be available to all interested parties on the company's website, http://www.angiotech.com under the Investors section.
Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP), please visit our website at http://www.angiotech.com.
CONTACT: Deirdre Neary, Manager, Investor Relations, Angiotech Pharmaceuticals, Inc., (604) 222-7056, email@example.com
|SOURCE Angiotech Pharmaceuticals, Inc.|
Copyright©2007 PR Newswire.
All rights reserved